Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FoxHollow Technologies Sells Stake to Merck - Medical Product Outsourcing

FoxHollow Technologies Sells Stake to Merck

FoxHollow Technologies, a medical device manufacturer, has sold an 11% stake in its business to collaboration partner and drug developer, Merck & Co. of Whitehouse, NJ, according to the Associated Press.
   Merck is buying $95 million worth of FoxHollow stock while investing an additional $100 million in the company during a four-year period to expand its collaboration agreement.
   Specifically, Merck will pay $40 million to the Redwood City, CA-based medical device maker over four years to collaborate exclusively in specified disease areas. Merck will pay Foxhollow $10 million per year, if the agreement is extended.
   The news boosted shares of FoxHollow rose $4.84, or 18 percent, to $32.09 in morning trading on the Nasdaq, as trading volume jumped to more than seven times the average level.
   Also, Merck will pay minimum of $60 million over the first three years of the agreement for research on removal of atherosclerotic plaque from arteries for analysis, clinical trials and drug profiling. FoxHollow will conduct the research activities and receive milestone and royalties on developed products.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters